MARIE TOMCZYK: Open Payments
NPI 1881224442 · APEX, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 31 payments from 12 companies in 2025. Trend: 2023 $400 · 2024 $461 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $165 |
| ABBVIE INC. | 5 | $111 |
| Xeris Pharmaceuticals, Inc. | 1 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
| Exact Sciences Corporation | 2 | $53 |
| Lilly USA, LLC | 3 | $47 |
| Amgen Inc. | 2 | $37 |
| Corcept Therapeutics | 1 | $36 |
| PFIZER INC. | 2 | $35 |
| ViiV Healthcare Company | 1 | $34 |
Products named: Wegovy, KEVEYIS, VRAYLAR, AIRSUPRA, Cologuard Collection Kit, Ozempic, QULIPTA, Korlym.
Industry payments across NC — which companies pay providers there.
